Article and Video CATEGORIES
I just did a brief video that appears on my The Swedish hospital website/blog, addressing the question of why it is standard to give single agent but not doublet or other combinations to patients who have already received first line therapy for advanced NSCLC. As I cover in the video, the basic premise is that as treatment continues for patients on therapy for advanced NSCLC, it becomes only more and more important to balance the anticipated side effects of treatments against the incremental benefit of a more aggressive treatment. Overall, most patients with metastatic/advanced NSCLC can tolerate and benefit meaningfully from a combination approach for initial therapy (though a targeted therapy will be preferred for the vast majority of patients with a "driver mutation" such as an EGFR mutation or ALK rearrangement). But beyond that point, as patients are experiencing cumulative effects from both the treatment and often the underlying cancer, the evidence reveals that combinations confer greater side effects but no accompanying significant improvement in overall survival.
Instead, the prevailing standard of care, with the evidence to support it, is a strategy sequential single agent treatments, which may lead to further tumor shrinkage in some patients and prolonged stable disease in many others; these results often lead to an improvement in survival with a manageable balance of often modest side effects.
I welcome any questions or comments you might have.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi Bluebird, Welcome to GRACE. I'm sorry you're going through this scare and hope it's just inflammation or from an infection you didn't know you had.
A CT would be...
Radiation + Brain Operation has just been discarded due to high risk. They will double Tagrisso dosis and then wait to see if it works, then try traditional Chemo. I would...
Hi and welcome to GRACE. I'm sorry to know you are entering a new stage. I'm not about to comment just now but wanted to let you know I see your...
Edit to say, we can't give advice but we can comment with views and facts. :)
My first thought is to ask if she has been seen at a large...
Hi Barbro, Welcome to GRACE. I'm sorry you're worrying about this. We aren't able to give feedback on scan reports. Interpreting scan reports in this setting is not only unethical but...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...